Note: This action is only applicable if your healthcare service prescribes, stores, supplies and/or administers medicines.
The prescribing, supply, storage and administration of medicines is regulated by legislation and jurisdictional requirements. These include:
- Therapeutic Goods Act 1989, Regulations and Orders set out the legal requirements for the import, export, manufacture and supply of therapeutic goods in Australia. This includes the requirements for inclusion of therapeutic goods in the Australian Register of Therapeutic Goods, including advertising, labelling and product appearance
- Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP) – commonly known as the Poisons Standard, collates decisions regarding the classification of drugs and poisons into different Schedules, and are included in relevant legislation of states and territories
- Poisons and controlled substances legislation in each state and territory. State and territory medicines and poisons regulation units – describe the legislative framework for who can prescribe, store, supply and administer medicines, based on the classification into different Schedules.
In addition, risks related to the prescribing, storage, supply and/or administration of medicines should be identified, recorded and mitigated where possible. For example, ‘look-alike, sound-alike’ (LASA) medicines are inherently at higher risk of errors in prescribing and supply. Strategies such as distinct signage, or separation of LASA medicines in storage areas may reduce the risks of these errors occurring. Guidance developed by the Commission outlines strategies and principles developed to address safe selection and storage of all medicines, including LASA medicines.
Temperature-sensitive medicines
Having effective processes in place will ensure that problems are detected early, responded to promptly, and managed before the integrity (safety, quality, potency and efficacy) of temperature-sensitive medicines is compromised.
Effective storage and response requirements will minimise the risk of ineffective vaccines or medicines being administered. Specific guidance is included in the latest edition of National Vaccine Storage Guidelines: Strive for 5.
Healthcare services should develop guidance on effective processes to ensure the integrity of the cold chain that includes:
- Audits of temperature control of storage facilities, including room temperature, refrigeration and frozen storage
- Regular testing and maintenance schedules for temperature alarms and temperature recording devices
- Safe transportation or transfer of temperature-sensitive medicines between storage areas or facilities (this could include receipt from manufacturers or wholesalers)
- Workforce orientation and training on cold chain management
- Action required in the event of a cold chain breach or temperature excursion.
Refrigerators (or cool rooms) of adequate size should be made available for the exclusive storage of vaccines or medicines that require storage between 2 °C and 8 °C, or lower temperatures where required. Alarms may need to be installed on refrigerators, cool rooms and medicine storage areas to alert of temperature changes. Systems and processes should be in place to maintain power to all refrigerators and cool rooms within the healthcare service at all times, with specific attention to active monitoring and contingency plans in instances of power outage, refrigeration failure or temperature changes that may compromise stored vaccines or medicines.
Implement policies, procedures and guidelines for disposal of unused, unwanted or expired medicines
Healthcare services that store medicines should review and implement work practices and distribution systems that minimise wastage, for example, by regular checking of stock expiry dates and stock rotation. Services should establish inventory management practices to eliminate wastage of medicines, such as minimising oversupply, and take a proactive and planned approach to changes to and routine review of the list of medicines held. The service should monitor usage patterns of medicines to identify unusual fluctuations and act based on this information.
The service should review and implement work practices that minimise waste, ensure safe handling and promote the efficient use of medicines. This includes consideration for the specific requirements for waste segregation and disposal of medicines.